Valsartan MDL Expanded To Include 2 Related Drugs Containing Carcinogen NDMA
WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 18 expanded the valsartan multidistrict litigation to include losartan and irbesartan, all high blood pressure drugs allegedly containing N-nitrosodimethylamine...To view the full article, register now.
Already a subscriber? Click here to view full article